XML 50 R39.htm IDEA: XBRL DOCUMENT v3.26.1

COMMON STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of options activity

Schedule of options activity
				Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
	Outstanding at December 31, 2024				606,452			$	5.29				2.0			$	514,394
	Granted				20,000			$	5.64				2.5			$	112,200
	Forfeited				(271,449	)		$	5.71				—			$	—
	Outstanding at December 31, 2025				355,003			$	5.00				1.8			$	2,219,665
	Exercisable at December 31, 2025				283,000			$	5.15				1.5			$	1,727,688
	Outstanding at December 31, 2025				355,003			$	5.00				1.8			$	2,219,665
	Granted				5,000			$	11.44				4.8			$	—
	Exercised				(15,000	)		$	4.69				—			$	—
	Forfeited/Expired				(20,000	)		$	4.18				—			$	—
	Outstanding at March 31, 2026				325,003			$	5.16				1.8			$	575,104
	Exercisable at March 31, 2026				251,334			$	5.24				1.5			$	408,018

Schedule of fair value of warrants

Schedule of fair value of warrants
		For the Three Months Ended March 31,
		2026				2025
Stock price		$	11.25			$	—
Exercise Price		$	11.44			$	—
Risk free interest rate			3.55	%			—
Expected term in years			5				—
Dividend yield			—				—
Volatility of common stock			93.67	%			—

Schedule of assumptions

Schedule of assumptions
Date of Grant		March 2, 2026
Stock Price		$	7.61
Exercise Price		$	9.00
Expected Remaining Term (Years)			5.00
Expected Volatility			92	%
Dividend Yield			0	%
Discount Rate - Bond Equivalent Yield			3.620	%

Schedule of warrants outstanding

Schedule of warrants outstanding
		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding at December 31, 2024			—			$	—				—			$	—
Warrants expired, forfeited, cancelled or exercised			—			$	—				—			$	—
Warrants issued			375,276			$	7.20				5.0			$	—
Outstanding at December 31, 2025			375,276			$	7.20				4.6			$	1,519,868
Exercisable at December 31, 2025			375,276			$	7.20				4.6			$	1,519,868
Outstanding at December 31, 2025			375,276			$	7.20				4.6			$	1,519,868
Warrants expired, forfeited, cancelled or exercised			—			$	—				—			$	—
Warrants issued			433,334			$	9.00				5.0			$	—
Outstanding at March 31, 2026			808,610			$	8.16				4.7			$	—
Exercisable at March 31, 2026			808,610			$	8.16				4.7			$	—

Schedule of restricted stock

Schedule of restricted stock
		Number of Shares				Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2024			—			$	—
Restricted stock granted			2,146,898			$	6.13
Restricted stock forfeited			(162,500	)		$	6.00
Restricted stock vested			(20,000	)		$	5.22
Unvested at December 31, 2025			1,964,398			$	6.15
Vested at December 31, 2025			20,000			$	5.22
Unvested at December 31, 2025			1,964,398			$	6.15
Restricted stock granted			420,000			$	10.70
Restricted stock forfeited			—			$	—
Restricted stock vested			(10,000	)		$	5.98
Unvested at March 31, 2026			2,374,398			$	6.95
Vested at March 31, 2026			30,000			$	5.47

X

- References

No definition available.

+ Details

Name:	duot_ScheduleOfFairValueWarrantsTableTextBlock
Namespace Prefix:	duot_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-8

+ Details

Name:	us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration